Clinical Trial Update: Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating paclitaxel in patients with advanced, refractory, or recurrent cervical or vaginal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Vaginal Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer, Vaginal Cancer | Phase 2 | Status: COMPLETED